Nuzenio

Cancer Drug Deals

Cancer Drug Deals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Sobi Inks $580 Million Deal With Innate Pharma for Skin Cancer Drug Lacutamab Ahead of Pivotal Trial - finance.biggo.comfinance.biggo.com · Mon, 10 Aug 2026 18:41:00 GMTSobi pens $580M deal for Innate’s cancer drug before ph. 3 push - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 11:13:48 GMTLigaChem Gains Sole Control of B7-H4 Cancer Drug With Distinct Tumor-Killing Mechanism - Tech TimesTech Times · Fri, 07 Aug 2026 18:29:26 GMTNew drug offers hope for small cell lung cancer patients - WKRCWKRC · Wed, 05 Aug 2026 21:32:03 GMTPathos AI Closes $2.3B Cancer Drug Deals to Prove AI Can Design Smarter Trials - Tech TimesTech Times · Tue, 04 Aug 2026 19:03:51 GMT

Timeline

Mon, 10 Aug 2026 18:41:00 GMTSobi Inks $580 Million Deal With Innate Pharma for Skin Cancer Drug Lacutamab Ahead of Pivotal Trial - finance.biggo.com
Mon, 10 Aug 2026 11:13:48 GMTSobi pens $580M deal for Innate’s cancer drug before ph. 3 push - Fierce Biotech
Fri, 07 Aug 2026 18:29:26 GMTLigaChem Gains Sole Control of B7-H4 Cancer Drug With Distinct Tumor-Killing Mechanism - Tech Times
Wed, 05 Aug 2026 21:32:03 GMTNew drug offers hope for small cell lung cancer patients - WKRC
Tue, 04 Aug 2026 19:03:51 GMTPathos AI Closes $2.3B Cancer Drug Deals to Prove AI Can Design Smarter Trials - Tech Times

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cancer Drug Deals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.